T and B Lymphocytes in Chronic Lymphocytic Leukemia

Peter Nowell, Ronald Daniele, David Rowlands, Larry Winger, Steven D. Douglas, Neil E. Kay, Clement C.s. Hsu, Stephen Davis

Research output: Contribution to journalLetter

5 Scopus citations

Abstract

To the Editor: Both B-cell and T-cell populations may increase in size and show altered functions during the course of chronic lymphocytic leukemia, but this action does not necessarily indicate that both are neoplastic, as suggested by Davis.1 T-cell numbers and responses to mitogens, for instance, may vary because of an immune reaction to infectious agents (or perhaps to neoplastic B cells),2,3 therapy or inhibitors in the serum.4 The best evidence that a suspected subpopulation is neoplastic may be its clonal nature, demonstrated immunologically or cytogenetically. This determination is difficult for the B cells in chronic lymphocytic leukemia, although.

Original languageEnglish (US)
Pages (from-to)504-505
Number of pages2
JournalNew England Journal of Medicine
Volume295
Issue number9
DOIs
StatePublished - Aug 26 1976

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'T and B Lymphocytes in Chronic Lymphocytic Leukemia'. Together they form a unique fingerprint.

  • Cite this

    Nowell, P., Daniele, R., Rowlands, D., Winger, L., Douglas, S. D., Kay, N. E., Hsu, C. C. S., & Davis, S. (1976). T and B Lymphocytes in Chronic Lymphocytic Leukemia. New England Journal of Medicine, 295(9), 504-505. https://doi.org/10.1056/NEJM197608262950915